Financials
Financial year 2025
Apotheek Bonte from Ieper, company number BE0804144351, closed financial year 2025 with a result of € 6,654 after tax. For that financial year Apotheek Bonte recorded a gross margin of € 74,617 and equity of € 14,962. Compared with financial year 2024, the result moved from € 173,308 to € 6,654. The company is profitable. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.
€ 14,962
▲ 80% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 6,654
▼ 96% vs 2024
Profit after tax over the fiscal year.
€ 119,227
▼ 16% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 9,962.
People and assets in 2025
0
Average over the fiscal year, from the social balance sheet.
€ 7,045
▼ 8% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 376,430
€ 27,204 is repaid this year. At this pace the long-term loan is gone in ≈ 14 years.
€ 339,411
▲ 9% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 2,170
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € 255,305 | € 74,617 | ▼ 71% |
| Profit after taxes | € 173,308 | € 6,654 | ▼ 96% |
| Equity | € 8,308 | € 14,962 | ▲ 80% |
| Total debts | € 652,142 | € 1,221,673 | ▲ 87% |
| Cash | € 141,642 | € 119,227 | ▼ 16% |
| Retained profit | € 3,308 | € 9,962 | ▲ 201% |
| Dividend | € 170,000 | € 0 | ▼ 100% |
| Bank debt | € 0 | € 376,430 | |
| Balance sheet total | € 660,450 | € 1,236,635 | ▲ 87% |
Key figures of Apotheek Bonte, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Apotheek Bonte?
What happened at Apotheek Bonte in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 6,654 (▼ 96% vs 2024). filed late Source: NBB ↗
- New establishment in Ieper. KBO
- Anne-Sophie Bonte became a director. NBB
- Start of the company according to the CBE. KBO
- MILDRO SA became a director. NBB
In short
From € 173,308 profit in 2024 to € 6,654 profit in 2025.
Paid € 2,170 in corporate taxes since 2024.
Best year ever: 2024, with € 173,308 profit.
Paid out € 170,000 in dividends to the owners in total.
Management
Behind Apotheek Bonte are MILDRO SA and Anne-Sophie Bonte. The same people are also behind CFA Pharma.
Directors
According to the 2025 annual accounts
since 2023
since 2023
Establishments
Establishment units
Physical locations of this company
Blauwepoortstraat 1
8902 Ieper
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0804.144.351
- VAT number
- BE 0804.144.351
- Registered office
- Blauwepoortstraat 1, 8902 Ieper
- Names & denominations
- Apotheek Bonte
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 19 July 2023
- Peppol
- Active · Active since 2 Jun 2026
- Activities · NACE
Detailhandel in farmaceutische producten
Groothandel in farmaceutische en medische artikelen
Detailhandel in drogisterijartikelen en onderhoudsproducten
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels
Detailhandel in drogisterijartikelen en onderhoudsproducten in gespecialiseerde winkels